More Plavix compensation claims have been filed by patients who allege bleeding as an adverse side effect from using the drug. Plavix (Clopidogrel) is a blood thinner prescribed for the prevention of blood clot and heart attacks. It has been linked to serious side effects such as heart attacks and strokes.
It is supposed to prevent bleeding ulcers, cerebral bleeding, gastro-intestinal bleeding and other problems.
The patients alleged that they suffered strokes and heart attacks after talking Plavix. The law suits claims that the drug can cause heart attacks, internal bleeding, strokes, blood disorders or death.
The US FDA first approved Plavix in 1997 for the prevention of heart attack and stroke. In 2005, the New England journal of medicine published a study comparing the effects of Plavix versus Aspirin and Nexium in patients who had ulcer bleeding.
The study reported an 8.6% increased risk of recurrence in patients taking Plavix versus 0.7% among those taking Aspirin and Esomeprazole. In the same year the FDA ordered that the Plavix label be updated to include information about reports linking Plavix to TTP, a condition marked by small clots through the entire circulatory system.